S&P 500 7,443.28 -0.19% NASDAQ 25,508.07 -0.05% DOW 51,839.26 -0.59% R2K 2,942.43 -0.67% VIX 17.51 -6.11% US 10Y 4.60 +1.26% DXY 100.89 -0.10% GOLD 4,069.30 +1.47% CRUDE 81.77 -1.75% BITCOIN 66,158.32 +1.42%
Next Bullish Trade
Sign in
IHE

IHE IHE

$98.85 -2.07 (-2.05%)
Neutral · +0.15σ

Price chart

Timeframe
Range

Loading…

Latest bar · IHE

Momentum reads · latest daily bar
Last
$98.85
-2.07 (-2.05%)
Mkt cap
$1.1B
Health
RSI(14)
53.5
neutral
Stochastic %K
41.2
neutral
MFI(14)
38.3
neutral
ADX(14)
25.9
trending

Green means room to run, red means stretched — the reads re-read live as you switch the chart's timeframe. MFI(14) is a volume-weighted money-flow read: above 80 = overbought, below 20 = oversold.

Top holdings

TickerName Weight
JNJ Johnson & Johnson 22.44%
LLY Eli Lilly and Co 22.25%
MRK Merck & Co Inc 4.55%
BMY Bristol-Myers Squibb Co 4.37%
RPRX Royalty Pharma PLC Class A 4.33%
VTRS Viatris Inc 4.22%
PFE Pfizer Inc 3.96%
ZTS Zoetis Inc Class A 3.73%
JAZZ Jazz Pharmaceuticals PLC 3.45%
ELAN Elanco Animal Health Inc 2.81%
Everything else 23.89%

Click any ticker to open its own chart page.

Sector / asset mix

Sector weightings

Healthcare
100.0%

Asset split

Stock
99.9%
Cash
0.1%

Fund profile

Expense ratio
0.38%
Total assets (AUM)
$1.14B
Distribution yield
1.48%
Category
Health
Fund family
iShares
Inception
May 01, 2006

Expense ratio is the annual cost of holding the fund; distribution yield is what it pays out.

Compare IHE vs peers

Line IHE up against up to 4 peers (5 tickers total) across ~30 metrics and get one weighted 0-100 verdict — best in green, worst in red. Peers also overlay on the chart above as rebased % lines, or flip the chart to the 2×2 grid for side-by-side mini charts.

Comparing IHE no peers yet — add up to 4 below

Add tickers to compare with IHE

~30 metrics across Snapshot, OdysseyHQ zone, Valuation, Growth, Quality, Technicals, Sentiment, and Risk — with a weighted score and a one-line read on each.

About IHE

The underlying index includes pharmaceutical companies such as manufacturers of prescription or over-the-counter drugs or vaccines. The fund generally will invest at least 80% of its assets in the component securities of its underlying index and may invest up to 20% of its assets in certain futures, options and swap contracts, cash and cash equivalents. The fund is non-diversified.